Trial Profile
Phase I/II Study of Celebrex and EPO906 in Patients with Metastatic Colorectal Cancer (CEPO906AUS10).
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Patupilone (Primary) ; Celecoxib
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions
- 23 Jun 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2017.
- 25 Mar 2015 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017 as reported by ClinicalTrials.gov record.
- 25 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.